MAPT and Alzheimer disease: Hyperphosphorylated TDP-43 proteinopathy occurs in ∼50% of FTD patients and has recently been described both in studies of ageing and in association with the cognitive impairment of ageing patients, especially in the context of tau and Aβ pathology (James et al., 2016), providing some overlap with AD (see poster).